In honor of Star Wars Day, get our Grantwriting Starter Bundle for a special price through May 6.

NIDDK Becomes The Latest IC To Pull Out Of The R21 Program

By Bouvier Grant Group

We stay current on NIH happenings and would be delighted to keep you informed.

NIDDK has become the latest IC to pull out of the Parent R21:

 

http://www2.niddk.nih.gov/Funding/Grants/ApplicantGuidelines/R21.htm

 

Because other large ICs had pulled out of the Parent R21 FOA, apparently DDK was getting saddled with R21s that might otherwise have gone elsewhere. R21 programs in general have had an increased number of applications in recent years, likely due to the fact that many ICs have pulled out of the R03 program.

 

Which begs the question: If you are a researcher who is passed the point of a mentored K-award, how do you step up to the R01, whose reviewers seem to have a nearly insatiable appetite for preliminary data? Why are the small-format R-series grants at NIH drying up?

Author:
Dr. Meg Bouvier

Margaret Bouvier received her PhD in 1995 in Biomedical Sciences from the Mount Sinai School of Medicine. After an NINDS post-doctoral fellowship, she worked as a staff writer for long-standing NIH Director Dr. Francis Collins in the Office of Press, Policy, and Communications for the Human Genome Project and NHGRI. Since 2007, Meg has specialized in editing and advising on NIH submissions, and began offering virtual courses in 2015. She's recently worked with more than 40% of the nation's highest-performing hospitals*, four of the top 10 cancer hospitals, three of the top five medical schools for research, and 14 NCI-designated cancer centers. Her experience at NIH as both a bench scientist and staff writer greatly informs her approach to NIH grantwriting. She has helped clients land over half a billion in federal funding. Bouvier Grant Group is a woman-owned small business.

*Our clients include 9 of the top 22 hospitals as recognized by the 2023/24 US News & World Report honor roll

Categories:
We read all NIH notices for our clients. When you join our mailing list, we’ll pass along important changes directly to your inbox, as well as opportunities to improve your grantsmanship skills.
Primary Position
Lead Source

Wait!

Subscribe to our monthly newsletter for the latest NIH news, grantwriting tips, and more.

NIH-October-2023-Newsletter